Allianz Asset Management’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$74.6M Buy
770,800
+255,647
+50% +$26.2M 0.08% 239
2025
Q4
$54.7M Buy
515,153
+12,407
+2% +$1.44M 0.06% 311
2025
Q3
$63.9M Buy
502,746
+42,741
+9% +$5.09M 0.07% 265
2025
Q2
$56.4M Buy
460,005
+63,356
+16% +$7.24M 0.07% 290
2025
Q1
$40.2M Buy
396,649
+118,056
+42% +$11.5M 0.05% 365
2024
Q4
$25.7M Buy
278,593
+80,504
+41% +$7.9M 0.03% 476
2024
Q3
$19.1M Sell
198,089
-31,210
-14% -$2.8M 0.03% 554
2024
Q2
$19.7M Buy
229,299
+177,529
+343% +$14.9M 0.03% 497
2024
Q1
$4.28M Sell
51,770
-140,580
-73% -$10.3M 0.01% 926
2023
Q4
$12.8M Buy
192,350
+168,358
+702% +$10.9M 0.02% 614
2023
Q3
$1.61M Buy
+23,992
New +$1.65M ﹤0.01% 1533
2022
Q3
Sell
-24,278
Closed -$861K 1952
2022
Q2
$861K Buy
24,278
+1,169
+5% +$60K ﹤0.01% 1728
2022
Q1
$1.31M Sell
23,109
-45,863
-66% -$2.39M ﹤0.01% 1744
2021
Q4
$3.58M Sell
68,972
-38,749
-36% -$2M ﹤0.01% 1362
2021
Q3
$6.43M Buy
107,721
+31,062
+41% +$1.95M 0.01% 1183
2021
Q2
$4.76M Buy
76,659
+18,439
+32% +$1.23M ﹤0.01% 1139
2021
Q1
$3.79M Sell
58,220
-1,026
-2% -$66.9K ﹤0.01% 1167
2020
Q4
$3.9M Sell
59,246
-29,789
-33% -$1.75M ﹤0.01% 1129
2020
Q3
$4.6M Buy
89,035
+62,131
+231% +$3.19M 0.01% 1002
2020
Q2
$1.33M Sell
26,904
-19,267
-42% -$1.04M ﹤0.01% 1750
2020
Q1
$2.35M Sell
46,171
-415,705
-90% -$24M ﹤0.01% 1471
2019
Q4
$25.5M Sell
461,876
-52,255
-10% -$2.84M 0.02% 683
2019
Q3
$25.9M Sell
514,131
-282,730
-35% -$14.2M 0.03% 672
2019
Q2
$40.2M Sell
796,861
-115,361
-13% -$5.6M 0.04% 507
2019
Q1
$42.4M Sell
912,222
-201,422
-18% -$10.2M 0.04% 447
2018
Q4
$54.7M Buy
1,113,644
+57,102
+5% +$3.25M 0.06% 342
2018
Q3
$65.5M Sell
1,056,542
-140,460
-12% -$8.54M 0.06% 353
2018
Q2
$64.5M Buy
1,197,002
+34,420
+3% +$1.72M 0.06% 323
2018
Q1
$52.9M Buy
1,162,582
+102,941
+10% +$4.41M 0.05% 403
2017
Q4
$41.7M Sell
1,059,641
-87,480
-8% -$3.33M 0.03% 621
2017
Q3
$42.3M Sell
1,147,121
-85,122
-7% -$3.03M 0.04% 585
2017
Q2
$47.5M Sell
1,232,243
-214,221
-15% -$7.84M 0.05% 519
2017
Q1
$49.3M Buy
1,446,464
+443,853
+44% +$14.6M 0.05% 503
2016
Q4
$32.9M Buy
1,002,611
+130,414
+15% +$4.23M 0.03% 765
2016
Q3
$28.1M Sell
872,197
-28,675
-3% -$929K 0.03% 774
2016
Q2
$27.8M Buy
900,872
+713,950
+382% +$22.3M 0.03% 715
2016
Q1
$5.6M Sell
186,922
-123,864
-40% -$3.42M 0.01% 1401
2015
Q4
$8.62M Sell
310,786
-1,055,134
-77% -$30M 0.01% 1128
2015
Q3
$41.7M Buy
1,365,920
+19,931
+1% +$694K 0.05% 449
2015
Q2
$49.3M Buy
1,345,989
+202,489
+18% +$7.22M 0.05% 437
2015
Q1
$40.4M Sell
1,143,500
-592,350
-34% -$20.3M 0.05% 438
2014
Q4
$53.1M Buy
1,735,850
+308,614
+22% +$9.62M 0.06% 367
2014
Q3
$41.9M Sell
1,427,236
-62,284
-4% -$1.9M 0.05% 398
2014
Q2
$42.5M Buy
1,489,520
+1,127,263
+311% +$31.4M 0.05% 375
2014
Q1
$10.4M Sell
362,257
-33,437
-8% -$870K 0.01% 746
2013
Q4
$10.5M Buy
395,694
+358,990
+978% +$9.99M 0.01% 716
2013
Q3
$1.01M Sell
36,704
-4,023
-10% -$103K ﹤0.01% 1369
2013
Q2
$933K Buy
+40,727
New +$920K ﹤0.01% 1364

Other funds holding EHC

Allianz Asset Management's EHC Position: Q1 2026 in Review

Allianz Asset Management increased its Encompass Health (EHC) stake by 50% in Q1 2026, buying an estimated $26.2M and bringing the position to 770,800 shares worth $74.6M. The position accounts for 0.08% of the portfolio, ranked #239.

Allianz Asset Management first reported a position in EHC in Q2 2013 and has held it in 48 quarters since. 577 funds tracked by Wall St. Rank hold EHC as of Q1 2026.

  • Allianz Asset Management held 770,800 shares of Encompass Health worth $74.6M as of Q1 2026.
  • Allianz Asset Management bought 255,647 Encompass Health shares in Q1 2026, an estimated $26.2M.
  • Encompass Health made up 0.08% of Allianz Asset Management's portfolio in Q1 2026, its #239 holding.
  • Allianz Asset Management first reported a position in Encompass Health in Q2 2013 and has held it in 48 quarters since.
  • 577 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.

Based on Allianz Asset Management's 13F filing for Q1 2026, filed 11 May 2026.